Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Ralph Lauren Smart Shirt Will Measure Heart Rate And Calories Burned

Ralph Lauren’s big push into the world of wearable technology — a smart shirt that collects a range of data, including the wearer’s heart rate and number of calories burned — is set to hit retail Thursday. You may have first heard about the PoloTech shirt during last year’s U.S. Open, when the brand (the […]

Read More »

MEDA May Be Looking to Offload U.S. Operations Worth $1 Billion, Sources Say

GOTEBORG, Sweden — Could Meda AB be selling off its U.S. operations? Some sources are suggesting a deal could be in the works. Late Thursday, Bloomberg Business, citing “people familiar with the matter,” reported Sweden-based Meda was exploring options to sell off its U.S. operations which have an estimated value of $1 billion. Meda, which […]

Read More »

A Day After Investing $1.7 Billion in North Carolina, Novo Nordisk A/S Buys Two Indiana Biotech Companies

Novo Nordisk (NVO), headquartered in Copenhagen, Denmark, announced yesterday that it will buy Calibrium LLC and MB2 LLC, two private biopharma companies based in Indiana.   Calibrium, located in Carmel, Ind., focuses on developing drug candidates for diabetes and related metabolic diseases. It was co-founded by Fritz French, the company’s chief executive officer, and Richard […]

Read More »

Lilly Lung-Cancer Drug Stirs Price Debate

An experimental Eli Lilly (LLY 3.26 %) & Co. lung-cancer drug hasn’t reached the market, but some doctors are already arguing its price should be below average because the drug extended patient lives by only six to seven weeks in a clinical trial.   The pre-emptive price proposal—published on Thursday by the medical journal JAMA […]

Read More »

Johnson & Johnson to Open New HQ in Tampa, Bringing 500 New Jobs

Pharmaceutical powerhouse Johnson & Johnson (JNJ) will open a new $23.5 million North American shared services headquarters in Tampa, Florida Gov. Rick Scott‘s office announced Thursday.   The new site is expected to bring 500 jobs to Florida’s gulf coast and is expected to be operational sometime in the middle of 2016. Johnson & Johnson […]

Read More »

AMCP Is Disappointed in FDA’s Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products

ALEXANDRIA, Va., Aug. 27, 2015 /PRNewswire-USNewswire/ — The Academy of Managed Care Pharmacy (AMCP) is disappointed in the Food and Drug Administration’s (FDA’s) draft guidance and proposed rule that calls for biologics, including reference products and biosimilars, to bear a nonproprietary name with an FDA-designated suffix. For several years, AMCP has been seeking a decision from the […]

Read More »

FDA approves Amgen’s cholesterol-lowering drug Repatha

The U.S. Food and Drug Administration on Thursday approved Amgen Inc’s Repatha drug for patients with hereditary forms of high cholesterol and those with cardiovascular disease. Last month the FDA approved a similar drug from Regeneron Pharmaceuticals Inc and Sanofi SA. The drugs belong to a potent new class of injectable LDL-lowering drugs known as […]

Read More »

High blood pressure in pregnancy tied to family risk

For women with pregnancy-related high blood pressure, the higher risk of hypertension that follows them through life may be due not just to the episode in pregnancy but also to family risk factors, researchers say. Their study looked at 252 women who had high blood pressure during pregnancy, as well as their sisters and brothers […]

Read More »

U.S. vaccination rates high, but pockets of unvaccinated pose risk

The vast majority of U.S. kindergarten-age children are vaccinated against preventable diseases but sizable pockets of unprotected children still exist, posing a public health threat, according to a government study.   Only 1.7 percent of U.S. parents of kindergartners sought exemptions in 2014 from laws requiring children be vaccinated, according to the U.S. Centers for […]

Read More »

Long working hours tied to stroke risk

People who work at least 55 hours a week are significantly more likely to eventually suffer a stroke than people who work 35 to 40 hours a week, a recent study suggests. Previously, the same research team had linked longer working hours with an increased risk of type 2 diabetes, but only for those in […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom